Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove

Medicine

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection

Published: August 11, 2023 doi: 10.3791/65890

Summary

Laser capture microdissection of oral submucous fibrosis tissues allows for precise extraction of cells from histological regions of interest for the analysis of multi-omics data with morphological and spatial information.

Abstract

Oral submucous fibrosis (OSF) is a common type of potentially malignant disorder in the oral cavity. The atrophy of epithelium and fibrosis of the lamina propria and the submucosa are often found on histopathological slides. Epithelial dysplasia, epithelial atrophy, and senescent fibroblasts have been proposed to be associated with the malignant transformation of OSF. However, because of the heterogeneity of potentially malignant oral disorders and oral squamous cell carcinoma, it is difficult to identify the specific molecular mechanisms of malignant transformation in OSF. Here, we present a method to obtain a small number of epithelial or mesenchymal cells carrying morphological data and spatial information by laser capture microdissection on formalin-fixed paraffin-embedded tissue slides. Using a microscope, we can precisely capture microscale (~500 cells) dysplastic or atrophic epithelial tissue and fibrotic subepithelial tissue. The extracted cells can be evaluated by genome or transcriptome sequencing to acquire genomic and transcriptomic data with morphological and spatial information. This approach removes the heterogeneity of bulk OSF tissue sequencing and the interference caused by cells in non-lesioned areas, allowing for precise spatial-omics analysis of OSF tissue.

Introduction

Oral submucous fibrosis (OSF) is a chronic, insidious disease that develops mainly in the buccal mucosa and results in restricted mouth opening1. While OSF is a multifactorial disease, areca nut or betel nut chewing is the main cause of OSF2,3. Because of this geographically specific habit, OSF is predominantly concentrated in populations in Southeast and South Asia3. The common histological features of OSF include abnormal collagen deposition in the connective tissue beneath the oral mucosal epithelium, vascular stenosis, and occlusion1. OSF epithelial tissue can present with manifestations of atrophy or hyperplasia and even dysplasia when concomitant with oral leukoplakia4,5.

OSF is defined by the World Health Organization as a common oral potentially malignant disorder (OPMD) that exhibits the potential to progress to oral squamous cell carcinoma with a malignant transformation rate of 4%-6%6,7,8,9. The mechanism underlying the malignant transformation of OSF is complex10. Abnormal growth of the epithelium, including both dysplasia and atrophy, increases the potential for carcinogenesis, and senescent fibroblasts in the stroma may be involved in the malignant progression of OSF by inducing epithelial-mesenchymal transition (EMT) through reactive oxygen species (ROS) and other molecules10.

Technologies for spatial-omic analyses generated multi-omic data with morphological and spatial information that have provided insights into cancer mechanisms11,12,13. Here, we present a protocol to capture morphology-related cell populations from formalin-fixed paraffin-embedded OSF tissue by laser microdissection. Multi-omic analyses of these samples can overcome challenges with intratissue heterogeneity and increase understanding of the molecular pathology and mechanisms of malignant transformation in OSF14.

Subscription Required. Please recommend JoVE to your librarian.

Protocol

This study was approved by the institutional review board of Peking University School and Hospital. Informed consent was obtained from the patients. The tissue samples used in this study were deidentified. The study scheme is shown in Figure 1.

1. Sample preparation

  1. Cut formalin-fixed paraffin-embedded oral submucous fibrosis tissues into continuous sections of 3 µm and 10 µm thickness on a microtome.
  2. Unfold the sections in water and then fish out onto the slides. Fix the 3 µM and 10 µm sections on adhesion microscope slides (slide A) and PEN-membrane slides (slide B), respectively.
  3. Place the slides on a hot plate at 60 °C for 2 h.

2. Hematoxylin-eosin staining

  1. Place slides A and B in xylene (CAUTION) for 10 min and repeat this step thrice.
  2. Hydrate slides A and B in graded ethanol solutions in the order of 100%, 100%, 90%, 80%, and 70% for 1 min in each concentration.
  3. Place slides A and B in ultrapure distilled water for 30 s
  4. Place slides A and B in Harris hematoxylin dye solution for 90 s.
  5. Place slides A and B in ultrapure distilled water for 30 s and repeat this step thrice.
  6. Place slides A and B in div-hematoxylin solution (CAUTION) for 2 s.
  7. Place slides A and B in ultrapure distilled water for 30 s and repeat this step thrice.
  8. Place slides in A and B in 1% re-blue solution for 2 s.
  9. Place slides A and B in ultrapure distilled water for 30 s and repeat this step thrice.
  10. Place slides in eosin solution for 2 s.
  11. Place slides A and B in ultrapure distilled water for 30 s and repeat this step thrice.
  12. Dehydrate the slides in graded ethanol solutions in the order of 70%, 80%, 90%, 100%, and 100% for 2 s in each concentration.
  13. Place slide A in xylene for 3 min and repeat this step twice.
  14. Add a drop of mounting medium (CAUTION) to slide A and cover it with a cover glass.

3. Observation of histological morphology and laser capture microdissection

  1. Initiate the laser microdissection system and software (Figure 2).
  2. Place slide A on the slide stage and observe the histological morphology to identify the area of interest for laser microdissection.
  3. Remove slide A and place slide B inversely on the slide stage.
  4. Click the Unload button (Figure 2) to push out the collection device. Insert a polymerase chain reaction (PCR) tube into the collection device and ensure that the tube is held fixed. Click the OK button (Figure 3).
  5. Select a cap by clicking the corresponding red circle marking the Collector Device: Tube Caps. The selected circle will turn green.
  6. Click the Draw button and Draw + Cut button and use the mouse to sketch the area of interest.
  7. Click the Start Cut button to capture the area of interest; the captured sample will be collected by the cap (Figure 4).
  8. Click the Lower button to ensure that the captured sample is collected (Figure 5).
  9. Click the Specimen button to capture the next sample.
  10. Click the Unload button to unload the PCR tube with the captured sample.

Subscription Required. Please recommend JoVE to your librarian.

Representative Results

By performing laser microdissection of OSF tissues, we captured samples of dysplastic epithelium, stroma beneath the dysplastic epithelium, atrophic epithelium, and stroma beneath atrophic epithelial tissue (Figure 1).Through extracting DNA and low-depth whole genome sequencing, we were able to analyze morphology-related copy number alterations (CNA)15. CNA is a common form of genomic instability associated with an increased risk of malignant transformation in OPMD15,16. We detected different CNA patterns among four kinds of samples. As shown in Figure 6, CNA was present in epithelial samples but not in stroma samples. Although the samples originated from the same patient, the CNA pattern in the dysplastic epithelium was not the same as that in the atrophic epithelium. CNA in chromosomes 3 and 8 were detected in dysplastic epithelium, while CNA was detected at a lower frequency in chromosome 8 in atrophic epithelium.

Figure 1
Figure 1: The scheme of laser capture microdissection of oral submucous fibrosis samples. The tissues of epithelium and stroma with different patterns are captured by laser under a microscope. Please click here to view a larger version of this figure.

Figure 2
Figure 2: Laser microdissection software. A screenshot of the software showing the live panel. Please click here to view a larger version of this figure.

Figure 3
Figure 3: Collector device window. A screenshot of the software showing the collector device window for selecting the collection device. Please click here to view a larger version of this figure.

Figure 4
Figure 4: Capturing the sample in the area of interest. Clicking on the Start Cut button will allow capturing the area of interest. Please click here to view a larger version of this figure.

Figure 5
Figure 5: Captured sample. The captured sample can be seen in the cap of the PCR tube. Please click here to view a larger version of this figure.

Figure 6
Figure 6: Copy number alterations. The representative results of different patterns of copy number alterations among various samples. There are different copy number alterations between dysplastic epithelium and atrophic epithelium. Please click here to view a larger version of this figure.

Subscription Required. Please recommend JoVE to your librarian.

Discussion

This protocol reported a pipeline to capture OSF tissue samples with morphological and spatial information for further spatial-omic analyses through laser microdissection. From the representative results, we identified different CNA patterns among various morphology-related samples.

OSF, a type of OPMD, is a common precancerous condition of oral squamous cell carcinoma6. Genomic instability has been reported to be associated with the development and malignant transformation of OPMD17,18. Multiple studies have reported chromosome alterations, differential gene expression, and epigenetic variations associated with the progression and malignant transformation of OSF from genomics, transcriptomics, and proteomics data19,20,21,22,23,24. The carcinogenic components of areca nut, such as arecoline, not only led to the development of OSF, but the long-term stimulation also induced the senescence of fibroblasts and EMT and continuous production of reactive oxygen species (ROS), thus resulting in malignant transformation by regulating the immune microenvironment and signal pathways such as TGF-β and NF-κB signals5,10,21. However, both abnormal epithelial and stromal histological changes are present in OSF tissues, and which tissue or cellular alterations drive the malignant transformation in OSF remains unclear. Previous studies have mostly used bulk sequencing analyses, in which DNA or RNA was extracted from a block of tissue to further analyze the molecular expression and involved pathways. However, this analysis lacked a morphological correlation with histology and ignored the intratissue heterogeneity; furthermore, this approach cannot identify whether there are differential molecular alterations in different histological areas.

Recent studies have reported spatial-omics analysis in many diseases11,13,25. Through precise spatial-omics analysis, increasing numbers of molecules and targets are being discovered and cellular interactions and clustering are being elucidated11,12,13. However, there is still a lack of spatially resolved omics analysis of OSF. OSF samples were usually taken from biopsies of oral mucosa and were prepared as small volumes of formalin-fixed, paraffin-embedded samples, making it difficult to perform single-cell spatial omics sequencing, which needs large samples. Therefore, the development of methods with spatial resolution using formalin-fixed paraffin-embedded samples might be a significant benefit. We expect the current protocol to benefit researchers working on OSF and other types of OPMD and contribute to understanding the mechanisms of the development and malignant transformation of OPMD.

This method has some limitations. First, the protocol was performed using formalin-fixed paraffin-embedded samples, making it difficult to extract RNA for sequencing analysis; however, morphology-related RNA sequencing analysis can be performed when using crystalline violet staining and maintaining aseptic practices15,26. The currently captured samples could not meet the level of single-cell resolution because when the number of cells is too small, the cells might be broken down by the laser beam, affecting DNA extraction.

Subscription Required. Please recommend JoVE to your librarian.

Disclosures

The authors declare no conflict of interest.

Acknowledgments

This work was supported by research grants from the National Nature Science Foundation of China (81671006, 81300894), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-038), National clinical key discipline construction project (PKUSSNKP-202102), Innovation Fund for Outstanding Doctoral Candidates of Peking University Health Science Center (BMU2022BSS001).

Materials

Name Company Catalog Number Comments
Adhesion microscope slides CITOTEST REF.188105
Div-haematoxylin YiLi 20230326
Eosin solution BASO BA4098
Ethanol PEKING REAGENT No.32061
Harris hematoxylin dye solution YiLi 20230326
Hot plate LEICA HI1220
Laser capture microdissection system LEICA LMD7 Machine
Laser microdissection microsystem LEICA 8.2.3.7603 Software
Micromount mounting medium LEICA REF.3801731
Microscope cover glass CITOTEST REF.10212450C
Microtome LEICA RM2235
PCR tubes AXYGEN 16421959
PEN-membrane slides LEICA No.11505158
Re-blue solution YiLi 20230326
Ultrapure distilled water Invitrogen REF.10977-015
Xylene PEKING REAGENT No.33535

DOWNLOAD MATERIALS LIST

References

  1. Cai, X., et al. Oral submucous fibrosis: A clinicopathological study of 674 cases in China. Journal of Oral Pathology & Medicine. 48 (4), 321-325 (2019).
  2. Cai, X., Huang, J. Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study. Oral Oncology. 130, 105949 (2022).
  3. Ray, J. G., Chatterjee, R., Chaudhuri, K. Oral submucous fibrosis: A global challenge. Rising incidence, risk factors, management, and research priorities. Periodontology 2000. 80 (1), 200-212 (2019).
  4. Shih, Y. H., Wang, T. H., Shieh, T. M., Tseng, Y. H. Oral submucous fibrosis: A Review on etiopathogenesis, diagnosis, and therapy. International Journal of Molecular Sciences. 20 (12), 2940 (2019).
  5. Cai, X., et al. The preliminary exploration of immune microenvironment in oral leukoplakia concomitant with oral submucosal fibrosis: A comparative immunohistochemical study. Journal of Oral Pathology & Medicine. , (2023).
  6. Warnakulasuriya, S., et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Diseases. 27 (8), 1862-1880 (2021).
  7. Cai, X., et al. Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders. Oral Oncology. 123, 105619 (2021).
  8. Murthy, V., et al. Malignant transformation rate of oral submucous fibrosis: A systematic review and meta-analysis. Journal of Clinical Medicine. 11 (7), 1793 (2022).
  9. Kujan, O., Mello, F. W., Warnakulasuriya, S. Malignant transformation of oral submucous fibrosis: A systematic review and meta-analysis. Oral Diseases. 27 (8), 1936-1946 (2020).
  10. Qin, X., Ning, Y., Zhou, L., Zhu, Y. Oral submucous fibrosis: Etiological mechanism, malignant transformation, therapeutic approaches and targets. International Journal of Molecular Sciences. 24 (5), 4992 (2023).
  11. Sun, L., et al. Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma. Cell Discovery. 9 (1), 28 (2023).
  12. Zhu, J., et al. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. Experimental & Molecular Medicine. 54 (11), 2060-2076 (2022).
  13. Ji, A. L., et al. Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma. Cell. 182 (2), 497-514 (2020).
  14. Van den Bossche, V., et al. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resistance Updates. 60, 100806 (2022).
  15. Li, X., et al. Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis. Science China. Life sciences. 64 (9), 1379-1391 (2021).
  16. Watkins, T. B. K., et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature. 587 (7832), 126-132 (2020).
  17. Odell, E. W. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral Diseases. 27 (8), 1993-2007 (2021).
  18. Wood, H. M., et al. The genomic road to invasion-examining the similarities and differences in the genomes of associated oral pre-cancer and cancer samples. Genome Medicine. 9 (1), 53 (2017).
  19. Venugopal, D. C., et al. Integrated proteomics based on 2D gel electrophoresis and mass spectrometry with validations: Identification of a biomarker compendium for oral submucous fibrosis-An indian study. Journal of Personalized Medicine. 12 (2), 208 (2022).
  20. Kundu, P., Pant, I., Jain, R., Rao, S. G., Kondaiah, P. Genome-wide DNA methylation changes in oral submucous fibrosis. Oral Diseases. 28 (4), 1094-1103 (2022).
  21. Cai, X., Zhang, H., Li, T. Multi-target pharmacological mechanisms of Salvia miltiorrhiza against oral submucous fibrosis: A network pharmacology approach. Archives of Oral Biology. 126, 105131 (2021).
  22. Xiao, X., Hu, Y., Li, C., Shi, L., Liu, W. DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications. Diagnostic Cytopathology. 48 (11), 1111-1114 (2020).
  23. Zhou, S., et al. Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis. Journal of Oncology. 2019, 6835176 (2019).
  24. Lunde, M. L., et al. Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and Southeast Asia using array-comparative genomic hybridization. Cancer Genomics & Proteomics. 11 (3), 127-140 (2014).
  25. Sun, C., et al. Spatially resolved metabolomics to discover tumor-associated metabolic alterations. Proceedings of the National Academy of Sciences of the United States of America. 116 (1), 52-57 (2019).
  26. Ma, M., et al. Copy number alteration profiling facilitates differential diagnosis between ossifying fibroma and fibrous dysplasia of the jaws. International Journal of Oral Science. 13 (1), 21 (2021).

Tags

Isolation Cells Morphological Information Spatial Information Oral Submucous Fibrosis Samples Laser Capture Microdissection Potentially Malignant Disorder Atrophy Epithelium Fibrosis Lamina Propria Submucosa Histopathological Slides Epithelial Dysplasia Senescent Fibroblasts Malignant Transformation Molecular Mechanisms Heterogeneity Oral Squamous Cell Carcinoma Specific Molecular Mechanisms Formalin-fixed Paraffin-embedded Tissue Slides Microscope Microscale Dysplastic Tissue Atrophic Epithelial Tissue Fibrotic Subepithelial Tissue Genome Sequencing Transcriptome Sequencing Genomic Data Transcriptomic Data
Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection
Play Video
PDF DOI DOWNLOAD MATERIALS LIST

Cite this Article

Cai, X., Zhang, H., Zhang, J., Li,More

Cai, X., Zhang, H., Zhang, J., Li, T. Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection. J. Vis. Exp. (198), e65890, doi:10.3791/65890 (2023).

Less
Copy Citation Download Citation Reprints and Permissions
View Video

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter